Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yefenof

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Harefuah|October 1, 1987
[The third component of complement (C3) and its contribution to the immune response]E Yefenof, E Klein
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesisE Yefenof, Y Ben-David
Leukemia Research|January 1, 1986
Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesisE Yefenof, Y Ben-David
Immunology Letters|June 1, 1993
Mitogenic activation of phosphoinositide turnover and DNA synthesis in murine CD4+8+ thymocytesR Guy, E Yefenof, Y Zilberman
Experimental Cell Research|December 1, 1974
Antibody-induced redistribution of surface antigen is independent of the amount of antigen and the cell cycle positionD Killander, E Yefenof, E Klein
Scandinavian Journal of Immunology|January 1, 1975
Surface markers on human B and T lymphocytes. VII. Rosette formation between peripheral T lymphocytes and lymphoblastoid B-cell linesM Jondal, E Klein, E Yefenof
The Journal of Experimental Medicine|December 1, 1980
In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesisE Yefenof, A Meidav, E Kedar
International Immunology|April 1, 1991
Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivityE Yefenof, B Asjö, E Klein
European Journal of Immunology|March 1, 1978
Shedding of anti-IgM from antibody-coated human lymphoma lines: differences between Epstein-Barr virus-negative lines and their virus-converted sublinesE Yefenof, L Lundin, G Klein
Immunobiology|July 1, 1985
Antigen non-specific activities in culture supernatant of ovalbumin-specific, cloned helper T lymphomaE Yefenof, R Feinman, E Kedar
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Harefuah|October 1, 1987
[The third component of complement (C3) and its contribution to the immune response]E Yefenof, E Klein
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesisE Yefenof, Y Ben-David
Leukemia Research|January 1, 1986
Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesisE Yefenof, Y Ben-David
Immunology Letters|June 1, 1993
Mitogenic activation of phosphoinositide turnover and DNA synthesis in murine CD4+8+ thymocytesR Guy, E Yefenof, Y Zilberman
Experimental Cell Research|December 1, 1974
Antibody-induced redistribution of surface antigen is independent of the amount of antigen and the cell cycle positionD Killander, E Yefenof, E Klein
Scandinavian Journal of Immunology|January 1, 1975
Surface markers on human B and T lymphocytes. VII. Rosette formation between peripheral T lymphocytes and lymphoblastoid B-cell linesM Jondal, E Klein, E Yefenof
The Journal of Experimental Medicine|December 1, 1980
In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesisE Yefenof, A Meidav, E Kedar
International Immunology|April 1, 1991
Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivityE Yefenof, B Asjö, E Klein
European Journal of Immunology|March 1, 1978
Shedding of anti-IgM from antibody-coated human lymphoma lines: differences between Epstein-Barr virus-negative lines and their virus-converted sublinesE Yefenof, L Lundin, G Klein
Immunobiology|July 1, 1985
Antigen non-specific activities in culture supernatant of ovalbumin-specific, cloned helper T lymphomaE Yefenof, R Feinman, E Kedar
Pageof 11